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jumonji Downregulates Cardiac Cell Proliferation
by Repressing cyclin D1 Expression
During this phase, growth signals are transduced from
the extracellular environment, ultimately reaching the
cell cycle machinery operating in the cell nucleus, which
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Rika Suzuki-Migishima,1 Yoshiko Motegi,1 is mainly regulated by molecules such as cyclins, cyclin-
dependent kinases (CDKs), and CDK inhibitors (CKIs).Minesuke Yokoyama,1 and Takashi Takeuchi1,*
1Mitsubishi Kagaku Institute of Life Sciences Complexes of G1 cyclins and their associated CDKs
trigger a cell cycle progression by phosphorylating criti-(MITILS)
11 Minamiooya, Machida cal proteins such as the retinoblastoma tumor suppres-
sor gene product (pRB) (for review, see Sherr, 1994).Tokyo, 194-8511
2 Graduate School of Environment and Information Thus, growth signals may influence the functions of G1
cyclin-CDK complexes.Sciences
Yokohama National University Five mammalian G1 cyclins have been enumerated to
date: cyclins D1, D2, D3 (D-type cyclins), and cyclins79-1 Tokiwadai, Hodogaya, Yokohama
Kanagawa, 240-8501 E1 and E2. Because the expression of D-type cyclins is
controlled by extracellular signals, D-type cyclins areJapan
regarded as functional links between the extracellular
environment and the cell cycle machinery (for reviews,
see Sherr, 1993, 1994). Although there are many reportsSummary
about the regulation of D-type cyclins, little is known
about regulation for cell proliferation in vivo during de-Spatiotemporal regulation of cell proliferation is nec-
velopment.essary for normal tissue development. The molecular
The jumonji (jmj) gene and jmj mutant mice were origi-mechanisms, especially the signaling pathways con-
nally obtained by a mouse gene trap strategy (Takeuchitrolling the cell cycle machinery, remain largely un-
et al., 1995). The trap vector was introduced into the jmjknown. Here, we demonstrate a negative relationship
gene and disrupted the gene. jmj heterozygous micebetween the spatiotemporal patterns of jumonji (jmj)
(jmj/trap) show no apparent abnormalities, whereas jmjexpression and cardiac myocyte proliferation. cyclin
homozygous mice (jmjtrap/trap), which lack jmj functions,D1 expression and cell proliferation are enhanced in
die in utero. These embryos have various abnormalitiesthe cardiac myocytes of jmj-deficient mutant embryos.
such as neural tube, cardiac, and hematopoietic defectsIn contrast, jmj overexpression represses cyclin D1
(Takeuchi et al., 1995, 1999; Motoyama et al., 1997;expression in cardiac cells, and Jmj protein binds to
Kitajima et al., 1999, 2001; Lee et al., 2000). The jmj genecyclin D1 promoter in vivo and represses its transcrip-
encodes a protein that is a member of the jumonji familytional activity. cyclin D1 overexpression causes hyper-
(for review, see Balciunas and Ronne, 2000) and the AT-proliferation in the cardiac myocytes, but the absence
rich interaction domain (ARID) family (for review, seeof cyclin D1 in jmj mutant embryos rescues the hyper-
Kortschak et al., 2000). The ARID is a DNA binding do-proliferation. Therefore, Jmj might control cardiac
main, and several members of this family are known tomyocyte proliferation and consequently cardiac mor-
be transcriptional factors and are involved in a varietyphogenesis by repressing cyclin D1 expression.
of biological processes (Kortschak et al., 2000).
We previously reported that the number of mega-Introduction
karyocyte lineage cells increased and the regulation of
growth arrest in these cells was affected in jmjtrap/trapCell proliferation is an important factor in various devel-
embryos (Motoyama et al., 1997; Kitajima et al., 2001)opmental processes in tissue morphogenesis and is
and that jmj overexpression in culture cells caused thestrictly regulated spatiotemporally so the tissue attains
inhibition of cell proliferation (Toyoda et al., 2000). Tothe necessary size, structure, and functions. Defects of
determine the distinct roles played by jmj in cell prolifer-the regulation result in disorganization of organogenesis
ation during development, we focused on the hyperpro-or tumor formation. There are complex signaling path-
liferation of cardiac myocytes (Takeuchi et al., 1999)ways under the regulation of cell proliferation, of which
among various phenotypes of jmjtrap/trap mice. In the pres-the cell cycle machinery would hold a central position.
ent study, we show that the jmj gene downregulates cellIt is still largely unknown, however, what molecules work
proliferation of cardiac myocytes by repressing cyclinin these pathways and how these pathways regulate the
D1 expression.cell cycle during development.
The control of cell proliferation by extracellular signals
Resultsoccurs largely during the G1 phase of the cell cycle.
Negative Relationship between Cardiac Myocyte
*Correspondence: take@libra.ls.m-kagaku.co.jp Proliferation and jmj Expression during3 These authors contributed equally to this work.
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Previously we reported that cardiac myocytes in ventri-tute for Child Health and Development, 3-35-31 Taishido Setagaya,
Tokyo, 154-8567. cles exhibited abnormal morphology that resulted from
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Figure 1. Development of the Cardiac Layers
(A) Sections of left ventricles stained with HE.
TL, trabecular layer; CL, compact layer. Scale
bar, 200 m.
(B) Cell numbers of cardiac myocytes in tra-
becular layer (TL) and compact layer (CL) of
left ventricles of jmj/ embryos. Numbers
were counted as described in Experimental
Procedures. All data are represented as
mean  standard error (SE) for three em-
bryos. Since the levels of SE were too low in
many instances, the error bars for these data
are not visible.
hyperproliferation in embryos lacking jmj functions et al., 1992a, 1992b; Poelmann et al., 2000; Zhao et al.,
2000), the patterns of proliferation (Figure 2A) would be(jmjtrap/trap embryos) at E10.5–E11.5 (Takeuchi et al., 1999)
(Figure 6C, trap/trap, CAD()). Cell density and the mi- one of the major factors determining the growth patterns
of these two layers (Figures 1A and 1B). In addition, thetotic index (MI) but not the cell area of trabecular myo-
cytes in the cardiac ventricles of jmjtrap/trap embryos are cell number and MI patterns suggested that proliferation
of the two layers was regulated differently. In fact, weincreased (Takeuchi et al., 1999). These results suggest
that jmj is involved in cardiac morphogenesis by nega- analyzed the effect of differences in the two layers on
the cell number (Figure 1B) and MI (Figure 2A) by a two-tive regulation of cell proliferation. Therefore, we first
examined the relationships between development of the way analysis of variance (ANOVA) and found significant
differences (F(1, 24)  14.555, p  0.001; F(1, 23)  100.383,ventricle, cardiac cell proliferation, and jmj expression.
The cardiac ventricles are composed of two layers of p  0.0001, respectively).
Next, expression of the jmj gene was examined (Figurecardiac myocytes, the trabecular and compact layers.
Figure 1A shows these two layers in the left ventricle 2B) using lacZ that was introduced into the jmj gene
(Takeuchi et al., 1995). Fused mRNA with a part of jmjfrom embryonic day 10.5 (E10.5) to E18.5. Growth of the
trabecular layer appeared to be greater than that of and lacZ is transcribed from the jmj gene. We have
confirmed that patterns stained with X-gal in the jmjthe compact layer in terms of volume at earlier stages
(E10.5–E12.5), while at later stages (E14.5–E18.5) this heterozygous mice reflect jmj expression patterns sen-
sitively in comparison with in situ hybridization with jmjrelationship appeared to be reversed. We measured the
cell number of each layer and found that the results cRNA and immunostaining with anti-JmJ antibodies in
various tissues and stages (Takeuchi et al., 1995; Toy-were consistent with the above observation (Figure 1B).
In order to determine the levels of proliferation, we oda et al., 2000; our unpublished data).
Expression of jmj in the trabecular layer was detectedmeasured the mitotic indices (MI) of the cardiac myo-
cytes in these two layers during development (Figure first at E10.5, around the 25-somite stage (S25), follow-
ing which the number of positive cells and intensity2A). There was an apparent peak of MI in trabecular
myocytes at E10.5. On the other hand, the MI of the rapidly increased. On the other hand, jmj expression
was detected first at around E12.5 in the compact layer,compact layer displayed a moderate peak around E9.5–
E11.5 and then gradually decreased after E12.5. The MI and the expression intensity gradually increased but
was weaker than that in the trabecular layer prior tocontinued to be higher than that of the trabecular layer
at almost all stages. Considering that the frequencies postnatal day 7, P7.
Thus, the stages when jmj expression started areof cell migration (from studies of the chicken heart) and
cell death of cardiac myocytes in the ventricles may not matched to the stages when MI started to decrease,
and the intensity of jmj expression and MI appeared tobe overly high during the corresponding stages (Mikawa
jumonji Downregulates Cardiac Cell Proliferation
87
Figure 2. Cell Proliferation and jmj Expression in the Cardiac Myocytes
(A) Mitotic indices (MI) of cells in compact layer (CL) and trabecular layer (TL) of left ventricles of jmj/ embryos. The MI for each individual
embryo is represented.
(B) Expression patterns of the jmj gene in the two layers of left ventricles during development (E10.5, S25 to P7). jmj expression was monitored
using lacZ, which was introduced into the jmj gene. Scale bar, 50 m.
(C) MI of cells in trabecular layer of left ventricles of jmj/ embryos (TL /) and jmjtrap/trap embryos (TL trap/trap).
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show a negative correlation in each layer (Figures 2A or between genotypes. The expression of cyclin D1 in-
creased at S24–S28 and then decreased in jmj/ em-and 2B).
bryos, while these expressions continued at high levels
in jmjtrap/trap embryos (Figure 3C). Interestingly, cyclin D1
Proliferation of Cardiac Myocytes Is Not expression patterns were similar to the patterns for the
Repressed in jmjtrap/trap Embryos mitotic indices (MI) of trabecular myocytes in normal and
The negative correlation described above suggests that mutant embryos (Figure 2C). Since cardiac myocytes
jmj may play a role in the repression of cell proliferation appear to be the most abundant type of cell in the ventri-
of cardiac myocytes during development. We therefore cles during S13–S37, the number of cells in the trabecu-
examined the pattern of MI in jmjtrap/trap embryos, in which lar layer might be greater than that in the compact layer
trabecular myocytes exhibited hyperproliferation. The (Figure 1B; about two times greater), and changes in
MI of cells in the trabecular layer in jmjtrap/trap embryos the pattern for MI in the compact layer are less drastic
showed higher levels and did not decrease at S35 (Fig- than in the trabecular layer (Figure 2A), the expression
ure 2C). The increase in the number of mitotic cells patterns of cyclin D1 in the ventricles would mainly re-
was also confirmed by staining with a mitotic marker, flect these in the trabecular layer.
phospho-histone H3 (labeling indices: jmj/, 0.42%; The expression of cyclin D1 protein was examined by
jmjtrap/trap, 1.49%, at S25). The MI of mutant embryos after immunohistochemistry to confirm whether the protein
E11.5 could not be measured because of embryonic level of cyclin D1 is enhanced in jmj mutant embryos.
lethality, which probably resulted from abnormal prolif- We found that the expression of cyclin D1 increased in
eration of cardiac myocytes. myocytes in the trabecular layer but not the compact
These results (Figures 1 and 2) suggest that expres- layer in jmjtrap/trap embryos compared to jmj/ embryos
sion of jmj downregulates the cell proliferation of cardiac at E10.5, S30–S31 (Figure 3D).
myocytes and is involved in cardiac morphology in nor- Together with the observation that jmj expression
mal embryos. starts around S25 at E10.5 (Figure 2B) in the trabecular
myocytes of normal embryos, these results suggest that
jmj downregulates cell proliferation by repressing cyclincyclin D1 Expression Is Not Repressed
D1 expression.in jmjtrap/trap Embryos
Hyperproliferation of trabecular myocytes in jmj mutant
jmj Overexpression Reduced cyclin D1 Expressionembryos suggests that jmj mutation influences the ex-
To test the hypothesis that jmj represses cyclin D1 ex-pression of cell cycle regulators. It is known that the
pression, we investigated the effects of jmj overexpres-control of cell proliferation by external growth signals
sion in the heart of embryos. For this purpose, we pro-occurs largely during the G1 phase. Therefore, we inves-
duced transgenic mice with the pCAJIE vector (Toyodatigated the gene expression of G1 cyclins and CKIs in
et al., 2000) (Figure 4A). In this vector, jmj cDNA is driventhe cardiac ventricles using an RT-PCR method (Figure
by the cytomegalovirus immediate-early enhancer and3A). The CKIs examined were the CIP/KIP family (p21,
-actin (CAG) promoter (Niwa et al., 1991), and its ex-p27, and p57).
pression can be monitored by GFP in transgenic mice.The embryos were analyzed in two stages, S25–S26
We found that preferential strong expression was oftenand S29–S31, when the mitotic indices of the trabecular
detected in the embryonic heart in the case of CAGmyocytes exhibited a peak and were on the decrease
promoter (our unpublished data), and we could establishwith jmj/ but not jmjtrap/trap embryos, respectively (Fig-
a transgenic mouse line, CAJ 17, which exhibits expres-ure 2C). No apparent difference between these two ge-
sion of GFP in the heart and part of the neural tissue atnotypes was detected in any gene expression at S25–
E10.5 (Figure 4B). The morphology of cardiac myocytesS26 (data not shown). At S29–S31, however, the
is normal in the ventricles of this transgenic mouse line.expressions of cyclin D1 in jmjtrap/trap embryos were ap-
Using this mouse line, we examined the effect of jmjproximately 5 times greater than in jmj/ embryos (Fig-
overexpression on cyclin D1 expression at S28 using aure 3A). The expressions of cyclin D3, cyclin E1, and p21
real-time RT-PCR method. jmj expression in the cardiacin jmjtrap/trap embryos appeared to show slight increases,
ventricles of transgenic embryos (CAJ()) increased ap-while those of cyclin D2, p27, and p57 showed no appar-
proximately four times compared to nontransgenic em-ent differences between the genotypes. We also exam-
bryos (CAJ()) (Figure 4C). The cyclin D1 but not D2,ined the expression of CDK4 and 6, catalytic subunits of
D3, or CDK4 expression levels in CAJ() embryos werecyclin D-dependent kinases, but detected no difference
significantly lower than that in CAJ() embryos (Fig-between genotypes (data not shown, for CDK4; see also
ure 4C).below).
These results from experiments of loss (Figure 3) andCyclin D is one of the first molecules responding to
gain (Figure 4) of function demonstrate that jmj reducedgrowth signals in the cell cycle machinery. Therefore,
cyclin D1 expression in the cardiac ventricles.we examined in detail the expression patterns of cyclin
D in the cardiac ventricles using a real-time quantitative
PCR method. First, we confirmed significant enhance- Jmj Binds to the cyclin D1 Promoter and
Represses Its Transcriptional Activityment of expression of cyclin D1 but not cyclin D2, D3,
or CDK4, in jmjtrap/trap embryos at S29–S31 (Figure 3B). From the results described above, we presumed that
Jmj protein would repress the transcriptional activity ofNext, we examined the expression patterns during de-
velopment (S24–S31). The expressions of cyclin D2, D3, cyclin D1. We examined this possibility by a transient
luciferase assay in COS-7 cells using fragments of theor CDK4 did not exhibit an apparent difference within
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Figure 3. cyclin D1 Expression Is Enhanced
in the jmjtrap/trap Cardiac Ventricles
(A) Wild-type (/) and jmj mutant (trap/trap)
embryos at S29–S31 were analyzed for ex-
pression of cyclin D1 (Cyc D1), cyclin D2 (Cyc
D2), cyclin D3 (Cyc D3), cyclin E1 (Cyc E1),
p21, p27, p57, and GAPDH in cardiac ventri-
cles by RT-PCR analysis. An aliquot of the
reverse transcription reaction was used for
serial dilutions of 1:5 and 1:25.
(B and C) mRNA levels of D-type cyclins and
CDK4 in cardiac ventricles were analyzed by
real-time quantitative PCR. (B) Expression
levels at S30–S31 relative to wild-type em-
bryos are represented as mean  standard
error (SE) for 3–5 embryos. *p  0.005 versus
wild-type embryos (Student’s t test). (C) Ex-
pression patterns at S24–S31. Levels relative
to one wild-type embryo (S30) in each gene
are represented.
(D) Enhanced expression of cyclin D1 protein
in jmjtrap/trap trabecular myocytes. Frozen sec-
tions of the left ventricles at E10.5, S30–S31
were analyzed by immunohistochemistry us-
ing an antibody against cyclin D1. Scale bar,
25 m. TL, trabecular layer; CL, compact
layer.
mouse cyclin D1 promoter (970 to 44; Figure 5A). 1999). We analyzed the effect of the GAL4 DNA binding
domain (GAL4 DBD) alone or the entire Jmj protein fusedExpression of Jmj by the jmj expression vector pCAJIE
caused cyclin D1 transcriptional activity to be repressed with GAL4 DBD (GAL4 DBD-Jmj) on the activity of the
SV40 promoter in which five copies of the GAL4 bindingsignificantly compared with the control vector without
jmj cDNA (Figure 5A, a). In order to identify the responsi- site were inserted upstream. GAL4 DBD-Jmj repressed
the promoter activity significantly compared with GAL4ble region for the repression by Jmj, we examined ef-
fects on a series of the terminal truncations or deletion DBD alone (Figure 5B). Because GAL4 DBD-Jmj did not
show repressive effects on the SV40 promoter lackingof cyclin D1 promoter (Figure 5A, b–g). We found that the
Jmj protein exhibited the repression of transcriptional the GAL4 binding site (data not shown), GAL4 DBD-Jmj
represses the promoter activity by binding specificallyactivity for all of the truncated cyclin D1 promoter, in-
cluding the region 187 to 44 (187/44; Figure 5A, to the GAL4 binding site, indicating that Jmj functions
as a transcriptional repressor. Furthermore, we mappede), except the minimum region (52/44; Figure 5A, f),
indicating that the region 187/52 is responsible for the repressor domain of Jmj using GAL4 DBD fusion
proteins with various Jmj deletion mutants. The resultsthe repression by Jmj protein. Indeed, Jmj protein
showed no effect on cyclin D1 promoter lacking this (Figure 5B) indicated that the N-terminal region of Jmj,
Jmj1-220, has repressor activity. Meanwhile, Jmj proteinregion (Figure 5A, g).
To test whether Jmj itself has repressor activity or lacking this 1–220 region (Jmj221-1234) localized in the
nucleus (data not shown) but lacked a repressive effectnot, we next employed a mammalian one-hybrid assay
modified to detect the repressor activity (Tanaka et al., on the cyclin D1 promoter (Figure 5B), showing that
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Figure 4. Repression of cyclin D1 Expression
by jmj Overexpression
(A) Schema for pCAJIE vector. IRES, internal
ribosomal entry sequence; EGFP, enhanced
GFP cDNA; PA, polyadenylation signal.
(B) Expression pattern of transgene in CAJ17
transgenic mice (CAJ()). CAJ(), nontrans-
genic mice. Left panels, bright fields; right
panels, dark fields for GFP observation. EGFP
is strongly expressed in the heart of a CAJ()
embryo (arrow). Scale bar, 500 m.
(C) mRNA levels of jmj, D-type cyclins, and
CDK4 in cardiac ventricles at S28 were ana-
lyzed by real-time quantitative PCR. Expres-
sion levels relative to CAJ() embryos are
represented as meanSE for three embryos.
*p  0.01 and **p  0.005 versus CAJ()
embryos (Student’s t test). cyclin D1 expres-
sion was reduced by jmj overexpression.
Jmj1-220 is required for repression of cyclin D1 pro- it is still unclear whether the hyperproliferation of trabec-
ular myocytes in jmjtrap/trap embryos resulted from a failuremoter.
The next question is whether Jmj binds to the cyclin D1 of repression of cyclin D1 expression. To answer this
question, we performed two experiments, overexpres-promoter. To determine this, we performed a chromatin
immunoprecipitation (ChIP) assay. The human cell line, sion of cyclin D1in jmj/mice (this section) and inactiva-
tion of cyclin D1 in jmjtrap/trap mice (next section).293T, was used because strong expression is possible
from transfected DNA and the nucleotide sequence of First, we produced transgenic mice overexpressing
cyclin D1 and examined whether the maintenance of athe cyclin D1 promoter is known. We confirmed that Jmj
represses activity of the human cyclin D1 promoter as high expression level of cyclin D1 can result in cardiac
myocyte hyperproliferation as observed in jmjtrap/trap em-well as that of mouse using a luciferase assay (data
not shown). A vector expressing T7 epitope-tagged Jmj bryos. For this purpose, we constructed the cyclin D1
expression vector pCADIE (Figure 6A). CAG promoterprotein (T7-Jmj) was transfected, T7-Jmj and chromatin
complex were immunoprecipitated with an anti-T7 anti- was used again, and we were able to monitor the expres-
sion of transgene by GFP in the same way as pCAJIE.body, and then the presence of the cyclin D1 promoter
It was expected that cyclin D1 overexpression wouldwas determined by PCR. T7-EGFP and Sp1 proteins
cause hyperproliferation in the heart and/or other tis-were used as negative and positive controls, respec-
sues and that transgenic mice (designated as CAD()tively, since Sp1 can bind to cyclin D1 promoter (Castro-
mice) would die in utero. Therefore, all founder miceRivera et al., 2001). Our assay showed that Jmj bound
were analyzed before birth. We analyzed transgenic em-to cyclin D1 promoter in vivo specifically (Figure 5C).
bryos which showed preferential or specific expressionThese results strongly suggest that Jmj binds to the
in the heart but not ubiquitous expression to avoid non-cyclin D1 promoter and represses transcriptional activity
cell-autonomous effects as much as possible (Figuredirectly using the repressor domain in Jmj protein.
6B). The trabecular myocytes of these embryos showed
abnormal morphology (Figure 6C) similar to jmjtrap/trap em-
cyclin D1 Overexpression Causes bryos (Takeuchi et al., 1999). The ventricles were filled
Hyperproliferation of Cardiac Myocytes with cardiac myocytes at E10.5 (S30–S31), and the myo-
Our results, as mentioned above, have shown that jmj cytes degenerated at E11.5 in both CAD() and jmjtrap/trap
expression represses cyclin D1 transcriptional activity. embryos (Figure 6C). The same results were obtained
However, it is not known if the repression of cyclin D1 in the multiple embryos. The MI of these cells in CAD()
embryos was significantly higher than that of CAD()by jmj can reduce proliferation levels. In the other words,
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Figure 5. Jmj Binds to cyclin D1 Promoter
and Represses Its Transcriptional Activity
(A) Jmj represses activity of cyclin D1 pro-
moter. Effects of Jmj expression on a series
of truncated constructs and a deletion con-
struct (g, 187 to 52 region was deleted)
in mouse cyclin D1 promoter were examined
using luciferase assay in COS-7 cells.
pCAJIE, an expression vector for Jmj; pCAIE,
a control vector expressing only GFP. All re-
sults are presented as mean of the relative
luciferase activity  SE of four separate ex-
periments. *p  0.05, **p  0.01, and ***p 
0.001 versus the corresponding control group
in each reporter construct (Student’s t test).
(B) Repressor activity of Jmj. We examined
the effects of GAL4 DBD fusion proteins with
various regions of Jmj on SV40 promoter with
GAL4 binding domain (5 GAL4-GL3 Con-
trol), and the effects of Jmj and Jmj 221–1234
on mouse cyclin D1 promoter (970/44) us-
ing luciferase assay. All results are presented
as mean of the relative luciferase activity 
SE of three separate experiments. *p 0.001
versus all other data without “*” including
each control (white bar) (Fisher’s LSD test
after one-way ANOVA).
(C) Binding of Jmj to cyclin D1 promoter in
vivo. Chromatin immunoprecipitation was
performed from 293T cells expressing T7-
Jmj, Sp1, or T7-EGFP with indicated antibod-
ies. The presence of target genes in the im-
munoprecipitates was detected by PCR with
primers that amplify cyclin D1 or -actin pro-
moters. 	T7, 	Sp1, and IgG represent experi-
ments immunoprecipitated with anti-T7 anti-
body, anti-Sp1 antibody, and mouse control
IgG, respectively. H2O and input templates
for PCR were H2O and genomic DNA in cell
lysate before immunoprecipitation, respec-
tively.
embryos (Figure 6E). High expression levels for cyclin hyperproliferation of cardiac myocytes in jmjtrap/trap em-
bryos.D1 mRNA and cyclin D1 protein in CAD() embryos at
Three double-mutant embryos (cyclin D1/ jmjtrap/trap)S30–S34 were confirmed by real-time RT-PCR (3.2- to
were obtained, and all embryos showed neural tube7.2-fold CAD() embryos) and immunohistochemistry
defects and abnormal heart shape (Figure 7A, arrow-(Figure 6D), respectively, and were similar to that for
head and arrow, respectively). However, myocyte mor-trabecular myocytes of jmjtrap/trap embryos (Figures 3B
phology in the trabecular and compact layers of all threeand 3D).
embryos was normal (Figure 7A). On the other hand, fiveThese results show that overexpression of cyclin D1
of six cyclin D1/ jmjtrap/trap littermates showed abnormalcauses cardiac myocyte hyperproliferation as observed
myocyte morphology (Figure 7A). This incomplete pene-in jmjtrap/trap embryos.
trance might be due to the fact that the genetic back-
ground was not uniform (N3 mice were used). Fisher’s
Cyclin D1 Inactivation in jmjtrap/trap Embryos exact test revealed a significant difference between
Rescues Hyperproliferation cyclin D1/ jmjtrap/trap and cyclin D1/ jmjtrap/trap embryos
of Cardiac Myocytes with respect to the frequency of embryos with abnormal
Next, we produced jmj and cyclin D1 double-mutant myocyte morphology (p  0.05). We examined MI of
mice by crossing and then analyzed the phenotypes. If trabecular myocytes of left ventricles (Figure 7B). Fish-
cyclin D1 is a major target of jmj with respect to cardiac er’s LSD test indicated that MI of cyclin D1/ jmjtrap/trap
embryos was significantly lower than that of cyclin D1/myocyte proliferation, the loss of cyclin D1 would rescue
Developmental Cell
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jmjtrap/trap (p  0.0037), but not that of cyclin D1/ jmj/ promoter which Jmj recognizes (Herber et al., 1994; Gut-
tridge et al., 1999; Joyce et al., 1999; Kitazawa et al.,embryos (p  0.5588), after obtaining significant differ-
1999; Shtutman et al., 1999; Eto, 2000).ence with one-way ANOVA (F(2,6)  12.512, p  0.0072).
One possibility is that Jmj protein or its protein com-These results showed that loss of cyclin D1 rescues
plex kicks out or inhibits the activities of all or part ofhyperproliferation of cardiac myocytes in jmjtrap/trap em-
these or unknown positive transcription factors, re-bryos and that jmj downregulates cardiac myocyte pro-
sulting in repression of transcriptional activity. Anotherliferation through cyclin D1.
possibility is that Jmj or unknown cofactors repress the
transcriptional activity, for example, by remodeling the
Discussion chromatin structure. It has been reported that histone
acetylase and deacetylase are recruited to transcrip-
During development, cell proliferation is regulated spa- tional complexes and are involved in transcriptional acti-
tiotemporally. In this paper, we have focused on the vation and repression, respectively (for reviews, see
relationship between jmj and downregulation of cell pro- Courey and Jia, 2001; Eisenman, 2001). Probably, the
liferation during cardiac development. Our studies sug- repressor domain of Jmj has crucial functions for the
gest that there is an active pathway downregulating cell repression, although no significant motives are found in
proliferation that works by repressing the expression of the region. Further analysis, such as identification of
gene(s) of the cell cycle machinery and that jmj functions the Jmj binding region in promoters of cyclin D1, and
as one of critical mediators in this pathway. cofactors of Jmj protein, would be helpful for under-
The proliferation of cardiac myocytes shows charac- standing the mechanisms of transcriptional regulation
teristic patterns during development (Figure 2A), and by Jmj.
that of trabecular myocytes in particular exhibit large Similar mechanisms would work in the compact layer
changes from E9.5 to E11.5 (Figure 2A). These changes as well as the trabeculae because jmj expression starts
are acutely upregulated and then downregulated. What just when the MI starts to decrease in cardiac myocytes
molecules control these changes? The proliferation of of the compact layer (Figures 2A and 2B). We speculate
cardiac myocytes, including trabecular myocytes, might that different regulation of jmj expression may be in-
be upregulated by growth factors such as FGFs, neureg- volved in different patterns of proliferation in the two
ulin, and IGF-I (MacLellan and Schneider, 1999). There layers. In addition, jmj probably continues to repress
is cell cycle machinery downstream of these mitogens, cyclin D1 expression in the cardiac myocytes since jmj
and complexes of G1 cyclins and their associated CDKs expression continues into adulthood (our unpublished
trigger a cell cycle progression. data).
As one of the mechanisms, an increase or decrease For correct regulation of CDK activities, the amount of
in cyclin D expression levels could up- or downregulate G1 cyclins, as well as CDK and CKIs, would be regulated
cell proliferation, respectively. In fact, we showed that within some range, as suggested by Drosophila studies.
the change in the expression level of cyclin D1 matched An increase or decrease of the Drosophila cyclin E level
well with that in the cell proliferation of trabecular myo- resulted in abnormalities in the arrest of cell proliferation
cytes (Figures 2C and 3C). Several signaling pathways (Knoblich et al., 1994). Three types of cyclin D (D1, D2,
and many transcription factors are known to activate and D3) are known in mammals, and all were expressed
the expression of cyclin D1 (for reviews, see Sherr and in cardiac myocytes of mouse embryos (Figure 3A). The
Roberts, 1999; Ekholm and Reed, 2000). Several of these total cyclin D amount would need to be within a certain
transcription factors are probably expressed in the em- range for normal proliferation. Since the amount of cyclin
bryonic heart and might control cell proliferation in tra- D1 increased (Figure 3D) in cardiac myocytes of jmj-
becular myocytes in a positive manner. We speculate deficient embryos, while those of cyclin D2 or D3 did
from the present study that once jmj is expressed in not change significantly (data not shown, and also see
cardiac myocytes, Jmj protein binds to the cyclin D1 Figure 3B for the mRNA levels), the total cyclin D amount
promoter and would antagonize, directly or indirectly, would increase and would be over the upper threshold,
these positive regulators of cyclin D1, resulting in repres- causing the hyperproliferation of cardiac myocytes (Fig-
sion of cell proliferation. In fact, there are some motifs ure 2C).
for transcription activators, such as SP1, CREB, NF- Meanwhile, in cyclin D1-deficient mice, the prolifera-
tion of cardiac myocytes of appears to be normal (Fantlkappa B, and LEF-1, around the region of cyclin D1
Figure 6. cyclin D1 Overexpression Causes Hyperproliferation in Cardiac Myocytes
(A) Schema of pCADIE vector. cyc D1, cyclin D1. For other abbreviations, see Figure 4A.
(B) Expression pattern of transgene in CAD() embryos at E10.5 (S30) and E11.5 (S40). Left panels, bright fields; right panels, dark fields for
GFP observation. EGFP is strongly expressed in the heart of both embryos (arrows). Scale bar, 500 m.
(C) Morphology of the left ventricles at E10.5 (S30–S31) (upper panels) and E11.5 (S39–S42) (lower panels). Sections were stained with HE.
Trabecular myocytes in CAD() embryos (middle panels) show abnormal morphology similar to jmjtrap/trap embryos (right panels). Scale bar,
50 m.
(D) Enhanced expression of cyclin D1 protein in myocytes in the left ventricle of CAD() mice. Frozen sections of CAD() (S34) and CAD()
(S33) embryos were analyzed by immunohistochemistry using an antibody against cyclin D1. Scale bar, 25 m.
(E) MI of trabecular myocytes of left ventricles of CAD() and CAD() embryos at E10.5 (S30–S34). MI values are presented as mean  SE
of two embryos. *p  0.005 versus CAD() embryos (Student’s t test). CAD() (jmj/ mice without a pCADIE transgene); CAD() (jmj/ mice
with a pCADIE transgene); trap/trap, CAD() (jmjtrap/trap mice without a pCADIE transgene).
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et al., 1995; Sicinski et al., 1995). Cyclin D2, D3, or E1 This is an important problem in not only our case, but
also in many studies concerning proliferation and differ-(Geng et al., 1999) possibly compensates for the loss
of cyclin D1. Furthermore, cardiac morphogenesis and entiation. We expect that jmj-deficient or cyclin D1-over-
expressing mice would be good tools to study this issue.the proliferation in embryos expressing a single D-type
cyclin appear to be normal, and upregulation of the Cell proliferation plays an important role during devel-
opment and is closely related with cell differentiation.remaining D-type cyclin was observed in several tissues
including the heart (Ciemerych et al., 2002). The total The signaling networks might be very complex; however,
they are accurately regulated. Of course, the jmj-cyclinamount of cyclin D would be within a normal range in the
heart of these mutant embryos due to the compensation. D1 pathway, described here, is one of the pathways
regulating cell proliferation during development, but fur-The cardiac phenotypes of our jmj mutant mice are
different from those of Lee et al. (2000), who did not ther studies on the pathway, especially the molecular
network including upstream and downstream mole-report hyperproliferation of cardiac myocytes. We have
shown that some jmj phenotypes, including hyperpro- cules, and tissue universality or specificity, would pro-
vide important insight into understanding the molecularliferation of trabecular myocytes, are dependent on ge-
netic background (Takeuchi et al., 1995, 1999; Moto- mechanisms of tissue morphogenesis and cell differen-
tiation.yama et al., 1997). Most likely, Lee and colleagues
analyzed jmj mutant mice with a C57BL/6 background.
We did not detect hyperproliferation of trabecular myo- Experimental Procedures
cytes in the same strain of mice.
MiceThe differences in phenotypes between two jmj mu-
We used mice with a C3H/HeJ Jcl (Clea JAPAN, Inc., Tokyo, Japan)tant mice led us to suspect that hyperproliferation of
genetic background. The jmjtrap/trap embryos were generated by inter-
cardiac myocytes is a result of a mutation in other crossing F7-18 jmj/trap mice with C3H/HeJ mice. cyclin D1 mutant
gene(s) but not jmj. However, this possibility can be mice (a FVB/NJ background, FVB.129S2(B6)-Ccnd1tm1Wbg, original
excluded, because exogenous jmj expression by trans- mice were reported by Sicinski et al., 1995) were obtained from The
Jackson Laboratory (Bar Harbor, ME). The heterozygous mice weregenesis rescued this phenotype as well as other major
backcrossed with wild-type C3H/HeJ mice twice and then crossedphenotypes of jmjtrap/trap embryos (our unpublished data).
once with jmj/trap mice to produce double heterozygous mice. Dou-In addition, enhanced expression of cyclin D1 in the
ble homozygous mice were obtained by crossing with these double
heart of jmj mutant embryos was decreased by exoge- heterozygous mice. Mice were genotyped by PCR as described
nous jmj expression. previously (Takeuchi et al., 1995; Sicinski et al., 1995). The presence
We have shown that expression levels of cardiac of a vaginal plug was regarded as E0.5.
markers such as MLC, MHC, and cardiac actin in trabec-
ular myocytes of jmjtrap/trap embryos were probably normal Generation of Transgenic Mice
at E9.5–E10, but decreased at E10.5 when cardiac myo- Expression vectors driven by the CMV- action promoter pCAJIE
(Toyoda et al., 2000) and pCADIE were used for overexpression ofcytes showed hyperproliferation (Takeuchi et al., 1999).
Jmj and cyclin D1, respectively, in transgenic mice. In the case ofBecause jmj expression starts in trabecular myocytes
pCADIE, the mouse full-length cyclin D1 cDNA (a kind gift from Dr.at E10.5 in normal embryos, jmj might be involved in
H. Matsushime) was inserted into pCAIE (Toyoda et al., 2000). The
maintenance of the differentiation state as well as in Jmj or cyclin D1 proteins were coexpressed with GFP by internal
negative regulation of cell proliferation. ribosome entry site (IRES).
The present results indicate that jmj downregulates Transgenic mice with pCAJIE or pCADIE were produced as de-
scribed previously (Hogan et al., 1994). The expression patterns andcardiac myocyte proliferation by direct repression of
intensity of transgenes were monitored by fluorescence of GFP orcyclin D1 expression. In addition, the expression levels
by real-time RT-PCR in embryos. A line of transgenic mice withof cardiac markers decreased in cardiac myocytes in
pCAJIE was established (designated as CAJ 17), and the expression
cyclin D1-overexpressing mice (data not shown). These of several genes in the ventricles was analyzed by real-time RT-
results suggest that the loss of jmj function results in PCR as described below.
overexpression of cyclin D1, and this overexpression
then causes both hyperproliferation and deregulation of Histology and Immunohistochemistry
maintenance of the differentiation state. The relation Embryos were dissected in Dulbecco’s phosphate buffered saline
(PBS) and fixed overnight at 4
C in Bouin’s fixative (Sigma Diagnos-between hyperproliferation and deregulation of differen-
tics, St. Louis, MO) for hematoxylin and eosin (HE) staining, overnighttiation is unknown. Although the possibility that jmj or
in 4% paraformaldehyde in PBS for immunohistochemistry, and forcyclin D1 is involved directly in differentiation cannot
30 min to 2 hr in 0.2% glutaraldehyde/1% formaldehyde/0.02%be excluded, we speculate that first, overexpression
NP40 in PBS for X-gal staining. HE staining and X-gal staining were
of cyclin D1 results in hyperproliferation, and then this performed as described previously (Takeuchi et al., 1999). For immu-
causes deregulation of differentiation because cyclin D1 nohistochemistry, frozen sections were stained with a mouse anti-
mouse cyclin D1 (Santa Cruz Biotechnology Inc, Santa Cruz, CA,functions to advance the G1 phase of the cell cycle.
Figure 7. Loss of Cyclin D1 in jmjtrap/trap Embryos Rescues Hyperproliferation of Cardiac Myocytes
(A) Morphology of a representative embryo of wild-type (/ /, S31), cyclin D1/jmjtrap/trap (/ trap/trap, S32), and cyclin D1/jmjtrap/trap
(/ trap/trap, S31) embryos. Upper, middle, and bottom panels show whole-mount views of embryos before fixation, front views of the
heart after fixation with Bouin’s solution, and sections of the left ventricles stained with HE, respectively. Scale bars, 500, 200, and 50 m,
respectively. Arrowheads and arrows represent neural tube defects and abnormal position of the right ventricles, respectively.
(B) MI of trabecular myocytes of left ventricles in embryos at E10.5 (S28–S38). MI are presented as mean  SE of three embryos. *p  0.01
and **p  0.005 versus cyclin D1/,jmjtrap/trap embryos (Fisher’s LSD test after one-way ANOVA).
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sc-450) or a rabbit anti-phospho-histone H3 antibody (Upstate Bio- was transferred to pGL3-Basic. The nucleotide sequence of each
construct was verified by DNA sequencing.technology, Lake Placid, NY, #06-570). The procedure for staining
was described in a previous study (Motoyama et al., 1997). For effector vectors expressing fusion proteins with GAL4 DBD
in a mammalian one-hybrid assay, jmj cDNA or its deletion mutantsThe number of cardiac myocytes in the trabecular and compact
layers was counted in areas 160 m wide in sections stained with were inserted into pBIND (Promega). In addition, jmj cDNA with a
stop codon at the upstream end was inserted into pBIND, and thisHE (Figure 1B). Three areas per section, two sections per embryo,
and three embryos per stage (E12.5–E18.5) were examined. vector was used as a control expressing GAL4 DBD alone.
Cells which showed chromosomes but neither nuclear membrane
nor nucleolus were counted as mitotic cells in sections stained with Transient Transfection and Luciferase Assay
HE, and the (number of mitotic cells/number of total cells)  100 In the luciferase assay of cyclin D1 promoter, COS-7 cells were
was presented as the mitotic index. More than 800 cells per embryo cotransfected when 60% confluent per 3.5 cm dish with 2 g of the
were examined as total cells in each layer after E10.5, and all count- GFP expression vector (pCAIE) as a control or the expression vector
able cells were examined at E9.0–E9.5. for Jumonji and GFP (pCAJIE), 1 g of the firefly luciferase reporter
vector pGL3 Basic (Promega Co.) including the cyclin D1 promoter,
and 0.05 g of pRL-CMV containing Renilla luciferase (PromegaConventional RT-PCR Analysis
Co.) using TransFast reagent (Promega Co.) according to the manu-Total RNA was isolated from the ventricles of one embryo on E10.5
facturer’s instructions. The pRL-CMV vector was used to normalizeusing RNeasy (Qiagen K.K., Tokyo, Japan). First strand cDNA syn-
for protein levels and transfection efficiency. After transfection (24thesis was performed using 5 l of heart RNA preparation with
hr), the COS-7 cells were lysated, and luciferase levels were mea-Superscript II and oligo (dT12-16) primer, as per the manufacturer’s
sured using the dual-luciferase reporter assay system (Promegainstructions (Invitrogen, Corp., Carlsbad, CA). The resulting template
Co.). In the mammalian one-hybrid assay, 5 GAL4-GL3 control (awas subjected to a PCR reaction using the following primers:
kind gift from Dr. T. Noguchi; Tanaka et al., 1999) or pGL3 controlGAPDH, 5-ACCACAGTCCATGCCATCAC-3, and 5-CACCCTGTT
(Promega) was used as a reporter vector, and experiments wereGCTGTAGCCGT-3; cyclin D (D1, D2, D3), common sense primer,
performed under almost the same conditions as described above,5-CTGGC(C/T)ATGAA(C/T)TACCTGGA-3 and specific antisense
except that 0.2g of reporter and 0.4g of effector were transfectedprimer, cyclin D1, 5-ATCCGCCTCTGGCATTTTGG-3 cyclin D2, 5-
and the cells were lysated after 30 hr of transfection.GTTCACTTCATCATCCTGCTG-3, cyclin D3, 5-CTGGTCTGACTG
GGCCCCTG-3; cyclin E1, 5-CGTTCTACTTGGCACAGGACT-3 and
ChIP Assay5-ATATGGCTTTCTTTGCTTGGGC-3; p21Cip1, 5-TCCCGTGGACAG
The assays were performed using a chromatin immunoprecipitationTGAGCAGTT-3 and 5-GACACACAGAGTGAGGGCTAAG-3; p27Kip1,
(ChIP) assay kit (Upstate Biotechnology) essentially as indicated by5-AGCTTGCCCGAGTTCTAC-3 and 5-TCCACAGTGCCAGCGTTC-
the manufacturer with minor modifications. Briefly, 293T cells in a3; p57Kip2, 5-ATCTGACCTCAGACCCAATT-3 and 5-CTCAGTTCC
10 cm diameter dish were transfected with expression vectors forCAGCTCATCAC-3; CDK4, 5-ATGGCTGCCACTCGATATGA-3 and
T7 epitope-tagged Jmj (pT7-Jmj), T7 epitope-tagged EGFP (pT7-5-CAAACACTAGGGTGACCTTG-3; CDK6, 5-CAGAGTAGTGCAT
EGFP), or human Sp1 (pEVR2-Sp1, a kind gift from Dr. Suske), andCGTGATCTGA-3 and 5-CCACCGAGGTAAGGGCCATC-3. PCR
then incubated 48 hr. The transfected cells were then used for thewas carried out by denaturing the DNA at 94
C for 1 min, followed
ChIP assay using mouse anti-T7-tag (Novagen, Darmstadt, Ger-by 35 cycles at 94
C for 1 min, 60
C for 1 min, 72
C for 2 min, and
many), rabbit anti-human Sp1 (Santa Cruz Biotechnology Inc., sc-59)a final extension step at 72
C for 8 min.
antibodies, or mouse control IgG (Sigma Diagnostics). DNA isolated
from the immunoprecipitates was then subjected to PCR amplifica-
Real-Time RT-PCR tion using primers: human cyclin D1 promoter (995/676), 5-GAG
cDNA obtained as described above, SYBER green PCR master mix GGGACTAATATTTCCAGCAA-3 and 5-TAAAGGGATTTCAGCTTA
(Applied Biosystems Japan, Tokyo, Japan) and iCycler iQ (BIO-RAD GCA-3; human -actin promoters (846/521), 5-TTACCCTCAA
Japan, Tokyo, Japan) were used according to the manufacturers’ AAGCAGGCAG-3 and 5-TTGCCGACTTCAGAGCAACTG-3. We
instructions. The same primers as those described above for cyclin performed PCR amplification using several primer sets for human
D1and CDK4 were used. Other primers for real-time PCR were: cyclin D1 promoter including the corresponding region in mouse
cyclin D2, 5-CTGGC(C/T)ATGAA(C/T)TACCTGGA-3 and 5-TCAT cyclin D1 promoter (187/52), which Jmj recognizes (Figure 5A).
TGAGCACATCCTTCGC-3; cyclin D3, 5-AACCCTGGCGGTTGCTC However, PCR products could not be amplified using even genomic
TTT-3 and 5-AGGAAAGACCTGTGACCCTA-3; jmj, 5-ACTTGT DNA before immunoprecipitaion (input) as a template, probably be-
GCTACCTGTCCATG-3 and 5-TCGTAGCGGTACATCAGCTT-3; cause of high GC content in the corresponding region (71.8%).
GAPDH, 5-GGGTGGAGCCAAACGGGTCATC-3 and 5- GCCAGT Therefore, we used primers described above.
GAGCTTCCCGTTCAGC-3. Real-time PCR was carried out, in tripli-
cate, by 45 cycles at 94
C for 1 min, 60
C for 1 min, and 72
C for 2 Statistical Analysis
min. The expected amplifications without other products including The experimental data were analyzed using the Student’s t test or
primer dimers were checked by melt curve analysis and gel electro- Fisher’s exact test. In addition, we used Fisher’s least significant
phoresis. For determination of the relative amount of products, stan- difference (LSD) test after obtaining a significant difference with
dard curve or comparative CT methods were used according to one-way analysis of variance (ANOVA) for multiple comparison tests
instructions of Applied Biosystems (user Bulletin #2, http://www. (Figures 5B and 7B). A two-way ANOVA was used to analyze the
site-at.com/users/pebio/pub/ts/SDS/UB7700/04303859rev.B.pdf). effect of each of two independent variables on a dependent variable.
To standardize the amount of sample cDNA, GAPDH was used as Using this test, we examined the effect of differences in cardiac
the endogenous control. layers on cell numbers or MI. Values of p  0.05 were considered
statistically significant.
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